A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema
Clinical trial NCT05121376 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05121376
- Sponsor
- BioMarin Pharmaceutical
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-15
- Primary completion
- 2028-11-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.